Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
1425 results
D3.433 - An effect on lipid profile of biologic therapy independent from weight variation
D3.434 - Effectiveness of Biologic Therapies in Adults With Chronic Rhinosinusitis With Nasal Polyps: Real-World Data
D3.435 - “Looking Twice in Atopic Dermatitis Therapy: Pruritus Is Not Always the Same, and Eczema Is Not Always Atopic Dermatitis”
D3.437 - Impact of benralizumab on fatigue and health-related quality of life in patients with hypereosinophilic syndrome: findings from the NATRON phase 3 trial
D3.438 - Clinical outcomes with navenibart according to baseline attack rate, body mass index, and age: results of the ALPHA-STAR trial
D3.447 - Pre-clinical Toxicology and Immunogenicity Evidence as a Precursor of the Successful Phase I/IIA Study with VLP Peanut
D3.454 - Do we still need aspirin desensitization therapy for nasal polyposis?
D3.462 - Polysorbate 80 (E433) sensitisation predicts and explains part of the variability of the Chronic Cough and Opposing Defiant Behaviour (ODB) in sensitised children: how the industrialised nutrition impacts the gut-brain axis and favours neuro-inflammation
D3.478 - Microsplenia: Spleen Size Reduction as a Comprehensive Biomarker for Immune-Related Diseases, Disease Monitoring, and Treatment Response
D3.479 - Association between Mitochondrial DNA Copy Number and Lung Function in Schoolchildren
D3.481 - Machine Learning–Based Plasma Proteomic Signatures for Prediction of Chronic Rhinosinusitis
D3.482 - Harnessing the Baseline Nasal Microbiome to Predict Pollen Related Symptom Expression
D3.483 - Wearable Energy-efficient Device development for Real-time Evaluation, Analysis, and Monitoring platform
D3.486 - Acute hepatitis B with atypical serological markers in a previously vaccinated patient receiving anti-CD20 obinutuzumab
D3.487 - Intersection of Micronutrient Malabsorption Symptoms and Iron Deficiency in a Diet interaction in East African Population
D3.492 - Validation of the Portuguese version of the Food Allergy Quality of Life Questionnaire Adult Form (P-FAQLQ-AF)
D3.50 - Molecular Characterization of Allergen Sensitization and Clinical Associations in a Romanian Cohort Using ALEX² Multiplex Assay
D2.276 - Clinical and Immunological Differences in Shellfish Allergy
D2.357 - Reductions in Hereditary Angioedema Attacks among Patients with C1 Esterase Inhibitor Deficiency who Switched from Another Long-Term Prophylaxis to Berotralstat
D2.360 - Hereditary Angioedema Attack Rates among Patients with Normal C1 Esterase Inhibitor Before and After Switching from Another Long-Term Prophylaxis to Berotralstat
Pagination
First page
First
Previous page
Previous
…
Page
64
Page
65
Page
66
Page
67
Page
68
Page
69
Page
70
Current page
71
Page
72
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download